about
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient dataInternational Society for Extracellular Vesicles: Second Annual Meeting, 17-20 April 2013, Boston, MA (ISEV 2013).Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia.Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis.Diagnosis of antiphospholipid syndrome in routine clinical practiceSyncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles.Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsiaEVpedia: a community web portal for extracellular vesicles research.An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation.The 2nd United Kingdom Extracellular Vesicle Forum Meeting Abstracts: 15 December 2015, Hadyn Ellis Building, Cardiff UniversitySelf-monitoring of oral anticoagulation: does it work outside trial conditions?Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis.A Comparison of Different Methodologies for the Measurement of Extracellular Vesicles and Milk-derived Particles in Raw Milk from Cows.Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayDifferential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.Incorporation of ophiobolin a into novel chemoembolization particles for cancer cell treatment.Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?Single particle analysis: Methods for detection of platelet extracellular vesicles in suspension (excluding flow cytometry).Impact of haemostatic mechanisms on pathophysiology of preeclampsia.Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.Identification of distinct circulating exosomes in Parkinson's diseasePlatelet activation responses in vitro to human mast cell activation.Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation.Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey.Measurement of refractive index by nanoparticle tracking analysis reveals heterogeneity in extracellular vesicles.Invisible vesicles swarm within the iceberg.Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility.Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system.Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing.Simultaneous assay of free and total protein S by ELISA using monoclonal and polyclonal antibodies.A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem™ PT).Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study.ObituaryMinimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesSoluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVIAn evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis.
P50
Q26865392-702DF1D0-CE6D-4DB6-8883-53E09DD21CBFQ30415840-4D5A0C8C-7EEF-478B-AB1C-AB5BE634D46DQ30610169-59167BE1-FE90-4BFF-A638-A12634ADE774Q33907783-331D35D4-948B-4976-B1FD-653C4444933AQ33939826-07FC6C94-F562-4728-BB8F-17E795C46BB6Q34056273-A9FCD0E0-9B4B-468F-9A91-4CB988E7D24DQ34455456-B0A4DC49-9031-4128-B77E-5B263F97DA49Q34599422-1E1E4C2F-9F97-4931-A28E-D84BA3C66339Q35108587-B9B11191-0858-4CCD-899A-AAF4C814CC8AQ35221358-A1EFE23A-6FF3-4184-A809-6C15D6CEB6C8Q36273503-8931B52D-5764-47F0-9439-10650103BB67Q36629928-C8B8456B-5720-467F-AC92-0E1F66D9A683Q37067806-FE5DAE52-9EB5-498A-BE97-2857A853033BQ37141158-76279446-4C83-4F33-814F-C98638A06A83Q37503490-A95C3FA3-DEDF-4F79-8CCD-685DAFCA737AQ37973203-E4CA8D0B-AD7E-465F-B6D2-958664D0F308Q38379177-8CBF29D8-B61C-4E4A-AB47-2E641483F249Q38905674-03E36DA4-2856-4913-B488-BB2302E44D04Q38998999-0E52DF18-A1A7-47E3-BFA6-DD2D5CDE624AQ39050585-A4AA8B9F-DEBF-4098-8EDE-BE660BA5D0CEQ39062138-15689E1C-3293-41CA-AB90-6C872630D348Q39163214-92CE0CE9-A3E8-452D-B3C8-29040421F48CQ39595928-B543D8F1-7CA1-457F-94BA-A105533522BDQ39760969-EDA96547-E56A-4661-85AB-F957C03B7AAFQ40936090-C6960B42-29EF-454A-8F72-23CF91F567DAQ41548432-BA385994-CA0B-40DF-A7AA-2482A5EFC4C2Q41643859-8070C8D8-68E0-4907-91E6-5075E7E99BC5Q43043548-A7D69B1A-8FFA-4D37-A14C-545D41BD984BQ45878081-EDA2C29B-144C-4573-B47E-8CFD2BF45A95Q46308335-3D047690-D614-4139-939B-398B33A98BC9Q46456127-515764B8-BB0B-4151-A094-25C6AF6BB066Q46745246-818F4685-6626-4DA7-9D01-341FF61E4CDEQ47173522-A7902BEC-0955-43D1-AFBE-E703A1ED5648Q47778852-AF470274-E161-4C18-BB9A-E406AF47D345Q48028227-C3B13CD3-6126-4239-88DC-D92F9F83D4F0Q53256817-AD965324-4798-47C5-BD0D-14C0DC951E64Q57084997-AD519E73-2D5F-4488-8FEB-4A2C5268800EQ60326168-029E0DB2-B410-43FD-81D1-F288923BB54EQ63407965-C960FEA6-D706-42C2-AA74-F3E96ADC0ABDQ64898626-DD5E56A9-88AD-4090-936D-192EB51F9723
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chris Gardiner
@ast
Chris Gardiner
@en
Chris Gardiner
@es
Chris Gardiner
@nl
type
label
Chris Gardiner
@ast
Chris Gardiner
@en
Chris Gardiner
@es
Chris Gardiner
@nl
prefLabel
Chris Gardiner
@ast
Chris Gardiner
@en
Chris Gardiner
@es
Chris Gardiner
@nl
P108
P106
P108
P1153
7006359228
7006359237
P31
P496
0000-0002-2318-0062